ArticleACS medicinal chemistry letters2023

Discovery of Futibatinib: The First Covalent FGFR Kinase Inhibitor in Clinical Use.

Satoru Ito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.